Increased plasma beta-endorphin levels in hereditary angioedema. 1989

R Perricone, and C Moretti, and C De Carolis, and G De Sanctis, and L Gnessi, and A Fabbri, and F Fraioli, and A E Panerai, and L Fontana
Dipartimento Chirurgico, II University of Rome, Tor Vergata, Italy.

We measured beta-endorphin (BE) and beta-lipotropin (BLPH) plasma concentrations (by means of an HPLC-RIA coupled method) during attacks as well as during symptom-free periods in a group of 28 patients with immunochemical (21) or functional (7) Cl inhibitor deficiency. Thirteen patients suffering from chronic urticaria served as controls. Three orders of considerations prompted us to initiate the present study: the clinical relationship between stress and the onset of acute episodes, the possible effects of repeated stressful situations, as are the attacks themselves, on the patients' neuroendocrine system and the well-known existence of close links between the immune system and endogenous opioids. The results show that plasma BE (and, to a lesser extent, BLPH) is dramatically increased during the attacks. In symptom-free periods many patients show very high BE concentrations, often in the presence of slightly elevated concentrations of BLPH and of ACTH. These observations suggest that patients with hereditary angioneurotic edema show a modified pro-opiomelanocortin-synthesizing cell activity that can result in a massive release of BE from the readily disposable pool present in the pituitary and/or an increase in the turnover of the peptide as evaluated by the BLPH/BE ratio.

UI MeSH Term Description Entries
D008083 beta-Lipotropin A 90-amino acid peptide derived from post-translational processing of pro-opiomelanocortin (POMC) in the PITUITARY GLAND and the HYPOTHALAMUS. It is the C-terminal fragment of POMC with lipid-mobilizing activities, such as LIPOLYSIS and steroidogenesis. Depending on the species and the tissue sites, beta-LPH may be further processed to yield active peptides including GAMMA-LIPOTROPIN; BETA-MSH; and ENDORPHINS. Lipotropin,Adipozin,beta-LPH,beta-Lipotrophin,beta LPH,beta Lipotrophin,beta Lipotropin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003174 Complement C1 Inactivator Proteins Serum proteins that inhibit, antagonize, or inactivate COMPLEMENT C1 or its subunits. Complement 1 Esterase Inhibitors,Complement C1 Inactivating Proteins,Complement C1 Inhibiting Proteins,Complement C1 Inhibitor Proteins,Complement C1r Protease Inhibitor Proteins,Complement C1s Esterase Inhibitor Proteins,Complement Component 1 Inactivator Proteins
D004744 Enkephalin, Methionine One of the endogenous pentapeptides with morphine-like activity. It differs from LEU-ENKEPHALIN by the amino acid METHIONINE in position 5. Its first four amino acid sequence is identical to the tetrapeptide sequence at the N-terminal of BETA-ENDORPHIN. Methionine Enkephalin,5-Methionine Enkephalin,Met(5)-Enkephalin,Met-Enkephalin,5 Methionine Enkephalin,Enkephalin, 5-Methionine,Met Enkephalin
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

R Perricone, and C Moretti, and C De Carolis, and G De Sanctis, and L Gnessi, and A Fabbri, and F Fraioli, and A E Panerai, and L Fontana
May 2014, International immunopharmacology,
R Perricone, and C Moretti, and C De Carolis, and G De Sanctis, and L Gnessi, and A Fabbri, and F Fraioli, and A E Panerai, and L Fontana
February 1986, Agressologie: revue internationale de physio-biologie et de pharmacologie appliquees aux effets de l'agression,
R Perricone, and C Moretti, and C De Carolis, and G De Sanctis, and L Gnessi, and A Fabbri, and F Fraioli, and A E Panerai, and L Fontana
February 1985, Journal of endocrinological investigation,
R Perricone, and C Moretti, and C De Carolis, and G De Sanctis, and L Gnessi, and A Fabbri, and F Fraioli, and A E Panerai, and L Fontana
January 1990, Alcohol (Fayetteville, N.Y.),
R Perricone, and C Moretti, and C De Carolis, and G De Sanctis, and L Gnessi, and A Fabbri, and F Fraioli, and A E Panerai, and L Fontana
February 1985, The Journal of clinical endocrinology and metabolism,
R Perricone, and C Moretti, and C De Carolis, and G De Sanctis, and L Gnessi, and A Fabbri, and F Fraioli, and A E Panerai, and L Fontana
January 1994, The Journal of emergency medicine,
R Perricone, and C Moretti, and C De Carolis, and G De Sanctis, and L Gnessi, and A Fabbri, and F Fraioli, and A E Panerai, and L Fontana
February 1993, Annals of emergency medicine,
R Perricone, and C Moretti, and C De Carolis, and G De Sanctis, and L Gnessi, and A Fabbri, and F Fraioli, and A E Panerai, and L Fontana
July 1988, Journal of the American Academy of Child and Adolescent Psychiatry,
R Perricone, and C Moretti, and C De Carolis, and G De Sanctis, and L Gnessi, and A Fabbri, and F Fraioli, and A E Panerai, and L Fontana
September 1985, Lancet (London, England),
R Perricone, and C Moretti, and C De Carolis, and G De Sanctis, and L Gnessi, and A Fabbri, and F Fraioli, and A E Panerai, and L Fontana
April 1981, Clinical endocrinology,
Copied contents to your clipboard!